Clover Biopharmaceuticals, Ltd. (CBPHF)

CIK 1856491 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Clover Biopharmaceuticals, Ltd..

Recent SEC filings

FiledFormAccession number
Apr 29, 2026D0001856491-26-000003
Apr 28, 2025D/A0001856491-25-000001
Apr 12, 2024D0001856491-24-000005
May 9, 2023D/A0001104659-23-057396
May 24, 2022D/A0001104659-22-064094
Apr 28, 2021D0001104659-21-056432